1. Home
  2. RLMD vs MWG Comparison

RLMD vs MWG Comparison

Compare RLMD & MWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • MWG
  • Stock Information
  • Founded
  • RLMD 2004
  • MWG 1988
  • Country
  • RLMD United States
  • MWG Singapore
  • Employees
  • RLMD N/A
  • MWG N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • MWG Miscellaneous manufacturing industries
  • Sector
  • RLMD Health Care
  • MWG Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • MWG Nasdaq
  • Market Cap
  • RLMD 11.5M
  • MWG 9.4M
  • IPO Year
  • RLMD N/A
  • MWG 2023
  • Fundamental
  • Price
  • RLMD $0.39
  • MWG $0.29
  • Analyst Decision
  • RLMD Hold
  • MWG
  • Analyst Count
  • RLMD 4
  • MWG 0
  • Target Price
  • RLMD $4.25
  • MWG N/A
  • AVG Volume (30 Days)
  • RLMD 881.7K
  • MWG 173.1K
  • Earning Date
  • RLMD 03-18-2025
  • MWG 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • MWG N/A
  • EPS Growth
  • RLMD N/A
  • MWG N/A
  • EPS
  • RLMD N/A
  • MWG 0.21
  • Revenue
  • RLMD N/A
  • MWG $35,736,000.00
  • Revenue This Year
  • RLMD N/A
  • MWG N/A
  • Revenue Next Year
  • RLMD N/A
  • MWG N/A
  • P/E Ratio
  • RLMD N/A
  • MWG $1.35
  • Revenue Growth
  • RLMD N/A
  • MWG 9.50
  • 52 Week Low
  • RLMD $0.34
  • MWG $0.23
  • 52 Week High
  • RLMD $7.22
  • MWG $0.78
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 27.23
  • MWG 49.62
  • Support Level
  • RLMD $0.36
  • MWG $0.24
  • Resistance Level
  • RLMD $0.49
  • MWG $0.30
  • Average True Range (ATR)
  • RLMD 0.04
  • MWG 0.02
  • MACD
  • RLMD 0.07
  • MWG -0.00
  • Stochastic Oscillator
  • RLMD 12.64
  • MWG 16.41

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

Share on Social Networks: